Net revenue declined 19% year-over-year as PGM prices fell, but cost savings and higher sales volumes supported margins. EBITDA dropped 8% and headline earnings fell 18%, with 2024 guidance unchanged and a strong net cash position maintained.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.